Type your tag names separated by a space and hit enter

Aromatase inhibitors vs. tamoxifen in postmenopausal women with early breast cancer

Aromatase inhibitors vs. tamoxifen in postmenopausal women with early breast cancer is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Aromatase inhibitors vs. tamoxifen in postmenopausal women with early breast cancer ID - 454308 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454308/all/Aromatase_inhibitors_vs__tamoxifen_in_postmenopausal_women_with_early_breast_cancer PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -